Want to see NAII full AI Analyst Report?
NAII Stock Chart & Stats
$3.15
-$0.10(-2.33%)
At close: 4:00 PM EST
$3.15
-$0.10(-2.33%)
Day’s Range― - ―
52-Week Range$2.14 - $4.96
Previous CloseN/A
Volume2.89K
Average Volume (3M)10.40K
Market Cap
$14.18M
Enterprise Value$71.72M
Total Cash (Recent Filing)$9.20M
Total Debt (Recent Filing)$65.17M
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.36
Shares Outstanding6,275,229
10 Day Avg. Volume14,152
30 Day Avg. Volume10,400
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.29
Price to Sales (P/S)0.15
P/FCF Ratio8.42
Enterprise Value/Market Cap5.06
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit7.23
Enterprise Value/Ebitda-37.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Ingredient/IPOwning and marketing CarnoSyn® provides a durable competitive advantage: branded ingredient recognition, IP protection, and licensing potential can sustain higher margins and recurring ingredient sales independent of volatile contract manufacturing revenues. This supports diversification and pricing power over the medium term.
Revenue Growth TrendPositive revenue growth, even modest, signals underlying demand stability in supplements and contract manufacturing. Sustained top-line growth helps improve utilization and can support margin recovery if fixed costs are absorbed, giving management room to restructure without immediate revenue erosion.
Equity Cushion On Balance SheetA material equity base provides a durable capital buffer to absorb continued losses and support operations while management executes turnaround plans. This cushion improves solvency prospects, preserves borrowing capacity relative to a near-zero equity base, and buys time to repair cash flow.
Bears Say
Weak Profitability & Low Gross MarginVery low gross margins and sustained operating losses indicate structural pressure on pricing or cost control in both manufacturing and ingredient segments. Low gross margin limits ability to cover fixed overhead, prolongs recovery, and reduces flexibility to invest in growth without materially improving unit economics.
Negative Cash GenerationOngoing negative operating and free cash flow create durable funding needs: the company must rely on external financing or asset sales to cover burn. This constrains capital allocation, increases liquidity risk, and can force short-term decisions that harm long-term competitiveness if cash pressure persists.
Finance Leadership TransitionA CFO departure during a period of losses and cash burn is a structural governance and execution risk. Even with temporary continuity from the president assuming duties, the transition can delay strategic finance initiatives, capital-raising, and timely reporting, increasing execution risk over the coming months.
Natural Alternatives International News
NAII FAQ
What was Natural Alternatives International’s price range in the past 12 months?
Natural Alternatives International lowest stock price was $2.14 and its highest was $4.96 in the past 12 months.
What is Natural Alternatives International’s market cap?
Natural Alternatives International’s market cap is $14.18M.
When is Natural Alternatives International’s upcoming earnings report date?
Natural Alternatives International’s upcoming earnings report date is Sep 23, 2026 which is in 67 days.
How were Natural Alternatives International’s earnings last quarter?
Natural Alternatives International released its earnings results on May 19, 2026. The company reported -$0.716 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.716.
Is Natural Alternatives International overvalued?
According to Wall Street analysts Natural Alternatives International’s price is currently Overvalued.
Does Natural Alternatives International pay dividends?
Natural Alternatives International does not currently pay dividends.
What is Natural Alternatives International’s EPS estimate?
Natural Alternatives International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Alternatives International have?
Natural Alternatives International has 6,275,229 shares outstanding.
What happened to Natural Alternatives International’s price movement after its last earnings report?
Natural Alternatives International reported an EPS of -$0.716 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.158%.
Which hedge fund is a major shareholder of Natural Alternatives International?
Currently, no hedge funds are holding shares in NAII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Alternatives International
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
Technical Analysis
Nature's Sunshine Products
―
Hain Celestial
―
USANA Health
―
LifeVantage
―
FitLife Brands
―
Ownership Overview
17.90% Insiders
9.33% Mutual Funds
14.15% Other Institutional Investors
53.51% Public Companies and
Individual Investors









